Advertisement
Screener

VERACYTE, INC. (VCYT) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

VERACYTE, INC. Number of Reportable Segments

VERACYTE, INC. (VCYT) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfReportableSegments · last filed 2026-07-31

  • VERACYTE, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
  • VERACYTE, INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
  • VERACYTE, INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
  • VERACYTE, INC. number of reportable segments for fiscal 2024 was 1.00 segment.
Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2026-06-301.00 segment
10-Q · filed 2026-07-31
2026-03-311.00 segment
10-Q · filed 2026-05-06
2025-12-311.00 segment
10-K · filed 2026-02-26
2025-09-301.00 segment
10-Q · filed 2025-11-05
2025-06-301.00 segment
10-Q · filed 2025-08-07
2025-03-311.00 segment
10-Q · filed 2025-05-08
2024-12-311.00 segment
10-K · filed 2025-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B